We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
+19.14%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$91.2M
AUM Growth
-$11.2M
(-11%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-28.87%
Top 10 Holdings %
Top 10 Hldgs %
83.1%
Holding
38
New
7
Increased
17
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VYNE Therapeutics
VYNE
|
+$4.29M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$591K |
| 3 |
ServiceNow
NOW
|
+$255K |
| 4 |
UnitedHealth
UNH
|
+$199K |
| 5 |
Autodesk
ADSK
|
+$171K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$7.74M |
| 2 |
Morgan Stanley
MS
|
+$1.05M |
| 3 |
Zevra Therapeutics
ZVRA
|
+$922K |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$265K |
| 5 |
Accel Entertainment
ACEL
|
+$258K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.05% |
| 2 | Financials | 25.1% |
| 3 | Communication Services | 18.31% |
| 4 | Technology | 5.89% |
| 5 | Consumer Discretionary | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
IBM
IBM
$200B
| $467K | 0.51% |
4,046
+502
| +14% | +$58.3K |
|
27
Intuit
INTU
$79.6B
| $306K | 0.34% |
1,033
+128
| +14% | +$35.1K |
|
|
28
ServiceNow
NOW
$106B
| $292K | 0.32% |
+3,605
| New | +$255K |
|
29
Automatic Data Processing
ADP
$102B
| $282K | 0.31% |
1,894
+235
| +14% | +$33.7K |
|
|
ACEL.WS
30
DELISTED
Accel Entertainment Inc Warrant
ACEL.WS
| $255K | 0.28% |
108,950
| – | – |
|
|
31
Autodesk
ADSK
$46.1B
| $208K | 0.23% |
+871
| New | +$171K |
|
|
32
UnitedHealth
UNH
$387B
| $205K | 0.22% |
+696
| New | +$199K |
|
33
Stryker
SYK
$123B
| $38K | 0.04% |
+211
| New | +$38.9K |
|
34
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $33K | 0.04% |
107
+64
| +149% | +$18.7K |
|
35
Amazon
AMZN
$2.66T
| – | – |
-2,160
| Closed | -$211K |
|
|
36
CALL
HCA Healthcare
HCA
$82.3B
| – | – |
-86,000
| Closed | -$7.73M |
|
|
37
HCA Healthcare
HCA
$82.3B
| – | – |
-86,160
| Closed | -$7.74M |
|
|
38
Zevra Therapeutics
ZVRA
$755M
| – | – |
-255,995
| Closed | -$922K |
|
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, DSC Advisors held 38 positions worth $91.2M, down 11% from $102M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
DSC Advisors withdrew a net $26.3M in Q2 2020, closing 4 positions and reducing 7 holdings. Its most notable exit was HCA Healthcare, an estimated $7.74M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Financials and Communication Services.
Against the trend, DSC Advisors opened a new position in ServiceNow worth $292K.
- DSC Advisors's largest Q2 2020 buy was ServiceNow: 3,605 shares worth $292K.
- DSC Advisors added most to VYNE Therapeutics in Q2 2020, an estimated $4.29M increase.
- DSC Advisors's biggest Q2 2020 reduction was Morgan Stanley, cutting an estimated $1.05M.
- DSC Advisors fully exited HCA Healthcare in Q2 2020, selling an estimated $7.74M.
- DSC Advisors's ten largest holdings make up 83% of its $91.2M portfolio in Q2 2020.
- DSC Advisors opened 7 new positions and closed 4 in Q2 2020.
- DSC Advisors's portfolio value fell 11% quarter-over-quarter to $91.2M.
Based on DSC Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.